Biotech companies with a high institutional following are more easily manipulated because they can buy options and screw with the stock price. I hope AVXL stays <50% insty.
the devil's advocate. I heard a lot of you guys from one side to the other. I don't know much about stock market and fibonaci and all that stuff. I think the key points here are clear to me, the road has already begun, we need patience and as for me Iam of the longest here believing in this approach- not amyloid removal-. Patience and certain things have to be done before considering to sell. Share price I don't care before FDA approval and proper clinical trial under way or partnership.
Market Data 
Markets 
AI
